Clinical Research Directory
Browse clinical research sites, groups, and studies.
Gadopiclenol vs Gadoxetate MRI for Liver Lesions
Sponsor: Icahn School of Medicine at Mount Sinai
Summary
The overall purpose of this study is to establish noninferiority of gadopiclenol MRI compared to gadoxetate MRI in terms of image quality and lesion detection/conspicuity in patients undergoing clinically indicated liver MRI in a prospective study. The research will be utilizing MRI; with enrollment goal of 75 subjects over the course of two years.
Official title: MR Image Quality and Liver Lesion Detection With Gadopiclenol: Comparison With Gadoxetate Disodium
Key Details
Gender
All
Age Range
18 Years - 89 Years
Study Type
OBSERVATIONAL
Enrollment
75
Start Date
2024-07-01
Completion Date
2026-03-27
Last Updated
2025-07-29
Healthy Volunteers
Yes
Conditions
Interventions
Radiology
Radiology - MRI Scans
Gadopiclenol
Gadopiclenol is a new macrocyclic gadolinium-based contrast agent (GBCA)
Locations (1)
BMEII
New York, New York, United States